Your Monthly Mounjaro Investment Breakdown
Monthly Costs by Dosage Strength
Understanding your monthly Mounjaro costs helps you budget effectively for your weight management treatment. Our prescription-only tirzepatide injections offer clear, transparent pricing with built-in savings for ongoing treatment.
Starting dose 2.5mg: £129.99 first month (with FIRST40 code), then £144.99 monthly. The 5mg strength costs £159.99 initially, reducing to £174.99 for subsequent monthly orders. Higher maintenance doses include 7.5mg at £209.99 first order (£224.99 ongoing), 10mg at £229.99 first order (£244.99 monthly), and 12.5mg at £259.99 initially (£274.99 ongoing).
Maximising Your Monthly Savings
EverydayMeds discount codes significantly reduce your monthly treatment costs. New customers save £40 on their first order with code FIRST40, whilst returning customers receive £25 off every monthly order automatically. This ongoing discount can save you £300 annually on your Mounjaro prescription.
Bundle options may offer additional monthly savings. Our Getting Started Duo packages combine two dosage strengths, reducing the per-pen cost when transitioning between strengths during your treatment journey.
Budgeting for Ongoing Treatment
Most patients require ongoing monthly treatment to maintain their weight management results alongside reduced-calorie diet and increased physical activity. Our returning customer pricing with automatic £25 monthly discounts makes long-term treatment more affordable.
Clinical assessment is included in all pricing - no additional consultation fees. Your monthly cost covers the prescription-only medicine, clinical review, and UK delivery. Express approval available for £20 additional if you need your monthly supply within 24 hours.
Order Your Monthly Supply
Start your clinical assessment today to receive your monthly cost calculation. Our GPhC-registered pharmacy team will determine your appropriate starting dose and provide clear ongoing pricing. Mounjaro injections are administered once weekly, with each pen lasting one month of treatment.
This prescription-only medicine may help regulate appetite and promote feelings of fullness when used alongside lifestyle changes. Subject to MHRA additional monitoring, all patients require clinical assessment before treatment commencement.
